Back to Find a Doctor
Dr. Joslyn Witherspoon

Dr. Joslyn N. Witherspoon, MD, MPH

Dr. Joslyn Witherspoon Davis is a board-certified family medicine physician with the Camp Creek Comprehensive Care Center since August 2020. Previously, she was a senior staff physician in the Department of Urology at Henry Ford Hospital in Detroit, Michigan. Dr. Witherspoon Davis is a native Detroiter and is a graduate of Spelman College, Class of 2000 where she majored in Biology and received a Bachelor of Science degree. She went on to complete a Master of Public Health degree with a concentration in Health Promotion and Disease Prevention from the George Washington University School of Public Health and Health Services in 2002. She received her Doctor of Medicine degree from the University of Texas Medical Branch in 2006.

Dr. Witherspoon Davis has completed a residency in Preventive Medicine from the University of Michigan, School of Public Health, as well as, a residency in Family Medicine at Henry Ford Hospital. She has special interests in dermatology and general medical urology. Dr. Witherspoon Davis is an accomplished researcher with several publications in respected clinical journals and books, as well as, touring internationally to present on various research topics. She has an extensive background in clinical trial research and preventive medicine with a strong interest in general health and wellness promotion.

Dr. Witherspoon Davis enjoys volunteering her time educating the community on healthy living, disease prevention, nutrition, and physical activity. Dr. Witherspoon is active in many community organizations and is dedicated to improving the health and well-being of her community.


  • Family Medicine


  • Grady

Honors & Awards

UTMB Honors in Research in Dermatology, Magna Cum Laude, 2006

Joseph B. Kass Award for Research, 2006

Walter Kleberg Award in Public Health, 2005


Joshi S, Ortiz S, Witherspoon JN, Rademaker A, West DP, Anderson R, Rosenbaum SE, Lacouture ME. "Effects of Epidermal Growth Factor Receptor Inhibitor-Induced Dermatologic Toxicities on Quality of Life" Cancer. 2010 Aug 15; 116(16):3916-23

Alam M, Ricci D, Havey J, Rademaker A, Witherspoon J, West D. "Safety of Peak Serum Lidocaine Concentration after Mohs Micrographic Surgery: A Prospective Cohort Study. J Am Acad Dermatol. 2010 Jul; 63(1):87-92

Alam M, White LE, Martin N, Witherspoon J, Yoo S, West D. "Ultrasound Tightening of Facial and Neck Skin: A Rater-Blinded Prospective Cohort Study." J Am Acad Dermatol. 2010 Feb; 62(2): 262-9

Fabi SG, Hill C, Witherspoon JN, Boone SL, West DP. "Frequency of Thromboembolic Events Associated with Thalidomide in the Non-Cancer Setting: A Case Report and Review of the Literature." J Drugs Dermatol 2009 Aug; 8(8):765-9

Witherspoon JN, Wagner R, Uchida T. "SPF Advertising Trends in Popular US Magazines." Skin Cancer 2008; 23 (1): 39-43.

Witherspoon JN, Wagner L, Rademaker A, West DP, Rosenbaum SE, Lacouture ME. "Correlation of Patient Characteristics and NCI-Common Terminology Criteria for Adverse Events (CTCAE) v 3.0 Grading with Dermatology-Related Quality of Life (QOL) in Patients with EGFR Inhibitor Induced Rash." J Clin Oncol 26:2008 (May 20 suppl; abstr 9559)

Witherspoon JN, White L, West D, Ortiz S, Yoo S, Havey J, Agha R, Martin N, Alam M. "Procedure for evaluating change in eyebrow position induced by ultrasound skin tightening." Journal of Investigative Dermatology, 128:S78, 2008

Alam M, Witherspoon JN, Zari S, Yoo S, Kundu R. "Salicylic Acid Peels vs. Q-Switched Laser for Treatment of Melasma: A Split-Face, Rater-Blinded Randomized Control Trial". Lasers in Surgery and Medicine. 2008.

Alam M, Witherspoon JN, Martin N, White L. "Transcutaneous Ultrasound for Tightening of Forehead, Cheek and Neck Skin: Incremental Benefit Associated with Repeat Treatment and Persistence of Clinical Efficacy". Lasers Surg Med Suppl, 40(S20):36, 99, 2008

Witherspoon JN, Huggins R, Rademaker A, Ortiz S, West D, Lacouture M. "Reduced Dermatology-Related Quality of Life (QoL) Associated with Skin Reactions Induced by Multikinase Inhibitors (MKIs) and Epidermal Growth Factor Receptor Inhibitors (EGFRIs)". Supportive Care in Cancer Journal, 2008

Havey J, Witherspoon JN, Schlosser BJ, Mekki M, Mirowski G. "Vulvar Pain Associated with Streptococcal Infection: Clinical Clues to a Definitive Diagnosis". American Academy of Dermatology 2009 Annual Meeting, Accepted, 2008

Joshi S, Ortiz S, Witherspoon JN, Lacouture ME. "Quality of Life (QOL) in Patients with Epidermal Growth factor Receptor Inhibitor (EGFRI)-induced Papulopustular Rash Compared to Historically Reported QOL for Common Dermatologic Disorders". American Academy of Dermatology 2009 Annual Meeting

Eilers RE, West DP, Ortiz S, Witherspoon JN, Lacouture ME. "Dermatologic Infections Complicate Epidermal Growth Factor Receptor Inhibitor (EGFRI) Therapy in Cancer Patients". American Academy of Dermatology 2009 Annual Meeting.

Alam M, Witherspoon JN, Ricci D, Havey J, Ortiz S, Yoo S. "Plasma Lidocaine Levels Associated with Use of Local Anesthesia (1% Lidocaine with 1:100,000 Epinephrine) During Mohs Micrographic Surgery. American Academy of Dermatology 2009 Annual Meeting

Witherspoon JN, Huggins R, Alam M. "Cosmetic Dermatology: Special Considerations in Indian/Near Eastern Skin". Cosmetic Dermatology in Skin of Color. McGraw-Hill, 2009

Witherspoon JN, Mirowski G, Schlosser BJ, Alam M, West DP. "Non-melanoma Skin Cancer." American College of Physicians, Handbook of Women's Health. ACP Press, 2009.